(Circulation. 1995;91:1697-1705.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Radiology and Nuclear Medicine (N.T., M.K., E.T., Y.M., Y.Y., J.K.); The Third Division (R.N., S.S.), Department of Internal Medicine; and Department of Cardiovascular Surgery (K.N., T.B.), Kyoto University Faculty of Medicine, Kyoto, Japan.
Correspondence to Nagara Tamaki, MD, Department of Nuclear Medicine, Kyoto University Faculty of Medicine, Shogoin, Sakyo-ku, Kyoto, 606 Japan.
Background Accurate noninvasive determination of myocardial viability is of paramount importance for the clinical identification of patients who will benefit most from revascularization. The preserved metabolic activity in the myocardium, as studied with positron emission tomography (PET), has been considered a gold standard for this purpose. However, recent reports show that moderate hypoperfusion or stress-induced ischemia may represent reversible ischemia. The present study was undertaken to compare the value of perfusion and metabolic studies with PET for predicting improvement in wall motion after revascularization.
Methods and Results Of 61 patients who had regional asynergy and
underwent PET before revascularization, 43 patients who had successful
revascularization were included in the study. Each patient underwent
rest-stress 13N-ammonia perfusion scans and
18F-fluorodeoxyglucose (FDG) scan at rest while in a
fasting state. Reversible ischemia was considered to be present
when the resting perfusion was
50% of the peak value, stress-induced
hypoperfusion was present, or an increase in FDG uptake was
observed. Of 130 asynergy segments, 51 segments had improved wall
motion after revascularization. The positive and negative predictive
values for improvement in asynergy were 48% and 87% by the rest
perfusion study, 63% (P=.05 versus the rest value) and 87%
by the rest-stress perfusion study, and 76% (P<.01 versus
the rest value) and 92% by the FDG study.
Conclusions FDG PET provided the best predictive value for improvement in wall motion after revascularization. On the other hand, 13N-ammonia PET is useful for predicting nonreversible myocardial scarring when it shows severe hypoperfusion at rest or hypoperfusion without stress-induced ischemia.
Key Words: tomography ischemia heart diseases
This article has been cited by other articles:
![]() |
W. Y. Szeto, R. C. Gorman, J. H. Gorman III, and M. A. Acker Ischemic Mitral Regurgitation Card. Surg. Adult, January 1, 2008; 3(2008): 785 - 802. [Full Text] |
||||
![]() |
Y.-W. Wu, E. Tadamura, M. Yamamuro, S. Kanao, A. Marui, K. Tanabara, M. Komeda, and K. Togashi Comparison of Contrast-Enhanced MRI with 18F-FDG PET/201Tl SPECT in Dysfunctional Myocardium: Relation to Early Functional Outcome After Surgical Revascularization in Chronic Ischemic Heart Disease J. Nucl. Med., July 1, 2007; 48(7): 1096 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. De Simone, I. Wolf, S. Mottl-Link, R. Hoda, B. Mikhail, F.-U. Sack, H.-P. Meinzer, and S. Hagl A clinical study of annular geometry and dynamics in patients with ischemic mitral regurgitation: new insights into asymmetrical ring annuloplasty Eur. J. Cardiothorac. Surg., March 1, 2006; 29(3): 355 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H.J.A. Slart, J. J. Bax, R. M. de Jong, J. de Boer, H. J. Lamb, P. H. Mook, A. T.M. Willemsen, W. Vaalburg, D. J. van Veldhuisen, and P. L. Jager Comparison of Gated PET with MRI for Evaluation of Left Ventricular Function in Patients with Coronary Artery Disease J. Nucl. Med., February 1, 2004; 45(2): 176 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Knuesel, D. Nanz, C. Wyss, M. Buechi, P. A. Kaufmann, G. K. von Schulthess, T. F. Luscher, and J. Schwitter Characterization of Dysfunctional Myocardium by Positron Emission Tomography and Magnetic Resonance: Relation to Functional Outcome After Revascularization Circulation, September 2, 2003; 108(9): 1095 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Egred, A Al-Mohammad, G D Waiter, T W Redpath, S K Semple, M Norton, A Welch, and S Walton Detection of scarred and viable myocardium using a new magnetic resonance imaging technique: blood oxygen level dependent (BOLD) MRI Heart, July 1, 2003; 89(7): 738 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Shimada, Y Sakanoue, Y Kobayashi, S Ehara, M Hirose, Y Nakamura, D Fukuda, H Yamagishi, M Yoshiyama, K Takeuchi, et al. Assessment of myocardial viability using coronary zero flow pressure after successful angioplasty in patients with acute anterior myocardial infarction Heart, January 1, 2003; 89(1): 71 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Gorman, J. H. Gorman III, and L. H. Edmunds Jr. Ischemic Mitral Regurgitation Card. Surg. Adult, January 1, 2003; 2(2003): 751 - 769. [Full Text] |
||||
![]() |
I. Matsunari, J. Taki, and N. Tonami Sequential Strategy Using Multimodality Viability Tests: Does It Work? J. Nucl. Med., June 1, 2002; 43(6): 803 - 805. [Full Text] [PDF] |
||||
![]() |
I. Matsunari, T. Yoneyama, S. Kanayama, M. Matsudaira, K. Nakajima, J. Taki, S. G. Nekolla, N. Tonami, and K. Hisada Phantom Studies for Estimation of Defect Size on Cardiac 18F SPECT and PET: Implications for Myocardial Viability Assessment J. Nucl. Med., October 1, 2001; 42(10): 1579 - 1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Haas, L. Jennen, U. Heinzmann, N. Augustin, M. Wottke, M. Schwaiger, and R. Lange Ischemically compromised myocardium displays different time-courses of functional recovery: correlation with morphological alterations? Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 290 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps A Tabulated Summary of the FDG PET Literature J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93. [Full Text] [PDF] |
||||
![]() |
H.-M. J. Siebelink, P. K. Blanksma, H. J. G. M. Crijns, J. J. Bax, A. J. van Boven, T. Kingma, D. A. Piers, J. Pruim, P. L. Jager, W. Vaalburg, et al. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: A prospective, randomized comparison of patients with suspicion of jeopardized myocardium J. Am. Coll. Cardiol., January 1, 2001; 37(1): 81 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Kim, E. Wu, A. Rafael, E.-L. Chen, M. A. Parker, O. Simonetti, F. J. Klocke, R. O. Bonow, and R. M. Judd The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction N. Engl. J. Med., November 16, 2000; 343(20): 1445 - 1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pasquet, M.S. Lauer, M.J. Williams, M.-A. Secknus, B. Lytle, and T.H. Marwick Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism Eur. Heart J., January 2, 2000; 21(2): 125 - 136. [Abstract] [PDF] |
||||
![]() |
F Fath-Ordoubadi, K J Beatt, N Spyrou, and P G Camici Efficacy of coronary angioplasty for the treatment of hibernating myocardium Heart, August 1, 1999; 82(2): 210 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jadvar, H. W. Strauss, and G. M. Segall SPECT and PET in the Evaluation of Coronary Artery Disease RadioGraphics, July 1, 1999; 19(4): 915 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schoder, R. Campisi, T. Ohtake, C. K. Hoh, D. H. Moon, J. Czernin, and H. R. Schelbert Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1328 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nakano, J.-D. Lee, H. Shimizu, T. Tsuchida, Y. Yonekura, Y. Ishii, and T. Ueda Reciprocal ST-segment depression associated with exercise-induced ST-segment elevation indicates residual viability after myocardial infarction J. Am. Coll. Cardiol., March 1, 1999; 33(3): 620 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Kitsiou, S. L. Bacharach, M. L. Bartlett, G. Srinivasan, R. M. Summers, A. A. Quyyumi, and V. Dilsizian 13N-ammonia myocardial blood flow and uptake: Relation to functional outcome of asynergic regions after revascularization J. Am. Coll. Cardiol., March 1, 1999; 33(3): 678 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. McFalls and H. B. Ward Flow-Metabolism Mismatch and Severe Ischemic Cardiomyopathy Circulation, November 17, 1998; 98(20): 2218 - 2218. [Full Text] [PDF] |
||||
![]() |
I. Matsunari, G. Boning, S. I. Ziegler, S. G. Nekolla, J. C. Stollfuss, I. Kosa, E. P. Ficaro, and M. Schwaiger Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using 18F-fluorodeoxyglucose J. Am. Coll. Cardiol., October 1, 1998; 32(4): 927 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Udelson Steps Forward in the Assessment of Myocardial Viability in Left Ventricular Dysfunction Circulation, March 10, 1998; 97(9): 833 - 838. [Full Text] [PDF] |
||||
![]() |
B. L. Gerber, J.-L. J. Vanoverschelde, A. Bol, C. Michel, D. Labar, W. Wijns, and J. A. Melin Myocardial Blood Flow, Glucose Uptake, and Recruitment of Inotropic Reserve in Chronic Left Ventricular Ischemic Dysfunction: Implications for the Pathophysiology of Chronic Myocardial Hibernation Circulation, August 15, 1996; 94(4): 651 - 659. [Abstract] [Full Text] |
||||
![]() |
H. R. Schelbert Different Roads to the Assessment of Myocardial Viability: Lessons From PET for SPECT Circulation, March 15, 1995; 91(6): 1894 - 1895. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |